Neuropad is a point-of-care test for people with diabetes to diagnose sudomotor dysfunction (inadequate sweat production), in the early stages of diabetic foot neuropathy.
 
Status In progress
Process MT
ID number 318

Project Team

Project lead Neil Hewitt

Email enquiries

Stakeholders

External assessment group King's Technology Evaluation Centre (KiTEC)
Manufacturers Skyrocket Phytopharma UK (UK distributor)
  TRIGOcare (manufacturer)
Manufacturers of related technologies not included in scope McCallan Medical Ltd
Others Birmingham Community Healthcare NHS Trust
  Boston Scientific
  Department for Health and Social Care (DHSC)
  Healthcare Improvement Scotland (HIS)
  Johnson & Johnson Medical Ltd
  Medicines and Healthcare Products Regulatory Agency (MHRA)
  NHS England (NHSE)
Professional groups Association of British Healthcare Industries (ABHI)
  Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care (AXrEM)
  Devices for Dignity
  Royal College of Physicians
  Royal College of Pathologists
  Medical Technology Group
  The British In Vitro Diagnostics Association (BIVDA)
Research groups Diabetes Frail

Timeline

Key events during the development of the guidance:

Date Update
08 May 2018 The final quality assurance step (Resolution) to ensure NICE acts fairly, has now taken place. The Resolution process is intended to identify errors or breaches of process before publication and respondents must specify which of these two grounds they are requesting resolution on. One or more resolution requests were received on this technology. An initial scrutiny meeting will take place on Friday 11 May 2018 to agree if there has been a breach on either grounds (for more information please see section 6 of the programme process guide). Guidance publication has been paused whilst this process is completed. Please contact medtech@nice.org.uk if you have any queries.
04 April 2018 Resolution
16 February 2018 Committee meeting: 2
22 November 2017 - 20 December 2017 Draft guidance
20 October 2017 Committee meeting: 1
20 April 2017 Scope published
20 March 2017 Stakeholder registration opens

For further information on how we develop guidance, please see our page about NICE medical technologies guidance